Ineffectiveness of Radiotherapy in Terminal Cancer Patients Approaching End of Life

Overview

This study evaluates the impact of an inpatient radiation oncology consult (IROC) service on the delivery of palliative radiotherapy (RT) to terminal cancer patients. Findings indicate that IROC implementation significantly reduced the rate of futile RT and associated hospital deaths among patients nearing end of life.

Background

Palliative radiotherapy can alleviate symptoms in terminal cancer patients but is often misapplied in those with limited life expectancy. The study highlights the importance of appropriate treatment selection to avoid unnecessary interventions that may not provide clinical benefit. Understanding the effectiveness of IROC services can help optimize care for patients approaching end of life.

Data Highlights

Key Findings

• 22.4% of patients received RT within 14 days of consultation.
• Implementation of IROC was associated with a decrease in RT delivery from 31.7% to 20.2%.
• The proportion of incomplete RT courses decreased significantly from 18.3% to 10.0% after IROC implementation.
• Fewer patients died in the hospital after receiving RT post-IROC (14.4% vs 23.9%).
• Most patients who received RT had their courses aborted before completion.

Clinical Implications

Healthcare providers should consider the limited benefits of palliative RT in patients with terminal cancer and prioritize supportive care. The implementation of IROC services may enhance decision-making and reduce unnecessary treatments, aligning care with patient goals.

Conclusion

The findings underscore the need for careful evaluation of palliative RT in terminal patients, with IROC services showing promise in reducing inappropriate interventions and improving end-of-life care.

Related Resources & Content

1. ASCO Post, 2015 -- ‘Substantial Number’ of Patients Requiring Palliative Radiotherapy for Stage IV NSCLC Are Overtreated
2. ASCO Post, 2023 -- GOG 258 Final Results: No Improvement in Survival by Adding Radiotherapy to Chemotherapy in Advanced Endometrial Cancer
3. ASCO Post, 2013 -- Patients Receiving Palliative Radiation Therapy for Metastatic Non–Small Cell Lung Cancer May Be Overtreated
4. ASCO Post, 2019 -- Adjuvant Chemoradiotherapy vs Radiotherapy Alone in High-Risk Endometrial Cancer
5. Journal of Clinical Oncology, 2024 -- Palliative Care for Patients With Cancer: ASCO Guideline Update
6. ScienceDirect, 2025 -- Palliative Radiotherapy within the Last 30 Days of Life: A Multi-Site Review of Practice Patterns
7. Palliative Care for Patients With Cancer: ASCO Guideline Update | Journal of Clinical Oncology
8. Palliative Radiotherapy within the Last 30 Days of Life: A Multi-Site Review of Practice Patterns - ScienceDirect